BCAX
Bicara Therapeutics Inc.
$21.60
+$0.31(+1.46%)
70
Overall
60
Value
81
Tech
--
Quality
Market Cap
$1.39B
Volume
234.27K
52W Range
$7.80 - $21.50
Target Price
$31.50
Key Metrics Overview
| Market Cap | $1.39B | P/E Ratio | N/A |
| 52W High | $21.50 | 52W Low | $7.80 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | N/A | 52W Position | 100.7% |
| Overall Score | 70 | Value Score | 60 |
| Quality Score | -- | Technical Score | 81 |
Growth Analysis
| EPS Current Est | $-2.72 | EPS Next Est | $-3.13 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCAX | $21.60 | +1.5% | 234.27K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bicara Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW